Crouse Health Urologist Andres Madissoo, MD, Introduces Aquablation Therapy for Enlarged Prostate Treatment

Crouse Health and AMP Urology are pleased to announce that Andres Madissoo, MD, is the first in Central New York to offer Aquablation® therapy with the new HYDROS™ Robotic System, the next-generation platform to treat men suffering from benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate.

The HYDROS Robotic System represents the next evolution in the delivery of Aquablation therapy. Leveraging insights from over 50,000 procedures, HYDROS features FirstAssist AI™ treatment planning, advanced image guidance, robotic resection, and a streamlined workflow. HYDROS is designed to improve efficiency, enhance surgeon and staff experience, and deliver a more accurate and consistent treatment plan for better clinical outcomes.

Aquablation therapy, now delivered by an AI-powered robotic system, is clinically proven to provide significant, durable BPH symptom relief while preserving sexual function and continence across prostates of all shapes and sizes.

Aquablation therapy uses the power of water delivered with robotic precision to remove prostate tissue. This leading-edge technology is clinically proven to provide significant, durable BPH symptom relief while preserving sexual function and continence across prostates of all shapes and sizes.

One out of every two men over the age of 50 is impacted by an enlarged prostate, a medical issue that makes urination difficult and weakens the bladder. By the time they reach age 70, 80% of males are dealing with symptoms, with approximately 12 million men in the U.S. currently being treated for the problem.

BPH can significantly impact quality of life; if untreated, its symptoms can affect bladder and kidney functions. “Men with enlarged prostates have a variety of treatment options available, which depend on symptoms and prostate size. Aquablation is a very powerful new tool, able to treat men with any size prostate in a short period of time,” said Dr. Madissoo, a partner in AMP Urology.

Aquablation’ s real-time ultrasound imaging provides the surgeon with a multi-dimensional view of the prostate, enabling personalized treatment planning tailored to each patient’s unique anatomy, says Dr. Madissoo. The surgeon can specify which areas of the prostate to remove while preserving the anatomy that controls erectile function, ejaculatory function, and continence. Once the treatment plan is mapped by the surgeon, the robotic-assisted procedure enables prostate tissue to be removed in a precise, targeted and controlled fashion.

The procedure is carried out under anesthesia, typically taking under an hour, and involves an overnight hospital stay. No incision is made in the abdomen, as the prostate is reached through the urethra, with aquablation therapy aiming to minimize both symptoms and side effects.

“I’m excited to bring aquablation therapy to our patients at Crouse Health and AMP,” said Dr. Madissoo. “This innovative treatment provides a new level of precision and safety, ultimately improving patient outcomes and quality of life. We are proud to be at the forefront of urological care in Central New York.”

Patients seeking more information about aquablation therapy or scheduling a consultation with Dr. Madissoo can contact AMP Urology at 315-478-4185 or visit ampofny.com.

About Crouse Health
Crouse Health, located in Syracuse, New York, is a leading Central New York healthcare provider offering a wide range of medical services to the community. With a commitment to patient-centered care and medical excellence, Crouse Health continually strives to improve the health and well-being of its patients.

About AMP Urology
Syracuse-based AMP Urology is dedicated to providing comprehensive and compassionate care for all urological conditions. Utilizing the latest technologies and treatments, AMP’s team of skilled specialists is committed to enhancing the quality of life for their patients.